| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044111555 |
| P356 | DOI | 10.1186/S13071-015-1159-9 |
| P932 | PMC publication ID | 4618738 |
| P698 | PubMed publication ID | 26489937 |
| P5875 | ResearchGate publication ID | 283872880 |
| P50 | author | María-Gloria Basáñez | Q28817184 |
| Luc E Coffeng | Q55188920 | ||
| Martin Walker | Q59773788 | ||
| Sake J de Vlas | Q63100920 | ||
| Wilma A Stolk | Q89944622 | ||
| P2860 | cites work | Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal | Q21144535 |
| A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti | Q28473329 | ||
| African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost | Q28485398 | ||
| Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis | Q28487047 | ||
| Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study | Q28534568 | ||
| Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution | Q28539071 | ||
| Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa | Q28546065 | ||
| Elimination of Onchocerciasis from Mexico | Q28546411 | ||
| Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme | Q28546650 | ||
| Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment | Q28652963 | ||
| Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework | Q30670487 | ||
| The potential impact of moxidectin on onchocerciasis elimination in Africa: An economic evaluation based on the Phase II clinical trial data | Q30936469 | ||
| Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections | Q33681574 | ||
| African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights | Q33716810 | ||
| Human infection patterns and heterogeneous exposure in river blindness. | Q34084959 | ||
| Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa | Q34202166 | ||
| The population dynamics of Onchocerca volvulus in the human host | Q34354188 | ||
| Determinants of the eradicability of filarial infections: a conceptual approach | Q34387018 | ||
| Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal | Q34431565 | ||
| Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study | Q34638307 | ||
| Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria | Q35183373 | ||
| Population biology of human onchocerciasis | Q35212363 | ||
| Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment | Q35372570 | ||
| Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon | Q35576027 | ||
| Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control | Q35811873 | ||
| The risk and dynamics of onchocerciasis recrudescence after cessation of vector control | Q36668688 | ||
| Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa | Q36795338 | ||
| A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area | Q36799187 | ||
| Can ivermectin mass treatments eliminate onchocerciasis in Africa? | Q36938108 | ||
| Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan | Q36944090 | ||
| Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin | Q37089613 | ||
| Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis | Q37159863 | ||
| Interruption of Onchocerca volvulus transmission in Northern Venezuela | Q37376623 | ||
| Mathematical models in the evaluation of health programmes | Q37863773 | ||
| Characteristics of persons who complied with and failed to comply with annual ivermectin treatment | Q38867971 | ||
| The LYMFASIM simulation program for modeling lymphatic filariasis and its control. | Q39359415 | ||
| ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis | Q39359420 | ||
| Periodic reproduction of Onchocerca volvulus | Q39440095 | ||
| The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. | Q41240516 | ||
| SCHISTOSIM: a microsimulation model for the epidemiology and control of schistosomiasis | Q41240529 | ||
| Studies on onchocerciasis in the United Cameroon Republic. II. Comparison of onchocerciasis in rain-forest and Sudan-savanna | Q43788817 | ||
| The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana | Q43935876 | ||
| Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities | Q44192803 | ||
| River blindness eliminated in Colombia | Q44369285 | ||
| The reproductive lifespan of Onchocerca volvulus in West African savanna | Q45145109 | ||
| Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments | Q45770627 | ||
| Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. | Q46320234 | ||
| Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year | Q46851395 | ||
| Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. | Q51157646 | ||
| Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. | Q52597863 | ||
| Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia | Q85957596 | ||
| P921 | main subject | ivermectin | Q415178 |
| onchocerciasis | Q1137321 | ||
| P304 | page(s) | 552 | |
| P577 | publication date | 2015-10-22 | |
| P1433 | published in | Parasites and Vectors | Q7135941 |
| P1476 | title | Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis | |
| P478 | volume | 8 |
| Q90929679 | Accelerating river blindness elimination by supplementing MDA with a vegetation "slash and clear" vector control strategy: a data-driven modeling analysis |
| Q44288385 | Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis. |
| Q36015457 | Between-Country Inequalities in the Neglected Tropical Disease Burden in 1990 and 2010, with Projections for 2020. |
| Q58717255 | Burden of onchocerciasis-associated epilepsy: first estimates and research priorities |
| Q99633690 | CRISPR-mediated Transfection of Brugia malayi |
| Q56910124 | Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda |
| Q37685567 | Comparison and validation of two mathematical models for the impact of mass drug administration on Ascaris lumbricoides and hookworm infection |
| Q28468411 | Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial |
| Q36508829 | Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review |
| Q57118117 | Control Strategies for Scabies |
| Q90118287 | Data-driven modelling and spatial complexity supports heterogeneity-based integrative management for eliminating Simulium neavei-transmitted river blindness |
| Q28602538 | Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness? |
| Q36507933 | Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus |
| Q40360250 | Factors affecting onchocerciasis transmission: lessons for infection control |
| Q33716373 | Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention |
| Q52627211 | From river blindness control to elimination: bridge over troubled water. |
| Q38977668 | Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity |
| Q93052457 | Genomic Epidemiology in Filarial Nematodes: Transforming the Basis for Elimination Program Decisions |
| Q59485071 | How can onchocerciasis elimination in Africa be accelerated? Modeling the impact of increased ivermectin treatment frequency and complementary vector control |
| Q91695904 | Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol |
| Q38642873 | Important progress towards elimination of onchocerciasis in the West Region of Cameroon |
| Q36275318 | Improving our forecasts for trachoma elimination: What else do we need to know? |
| Q55487312 | Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes. |
| Q41987224 | Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness |
| Q36708214 | Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis. |
| Q36257358 | Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes. |
| Q37006791 | Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings |
| Q91721725 | Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs |
| Q36303283 | Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal |
| Q53701529 | Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin. |
| Q26315231 | Onchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex |
| Q91816675 | Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis |
| Q92524117 | Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities |
| Q37045287 | Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results |
| Q36361450 | Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases |
| Q55255629 | Report of the first international workshop on onchocerciasis-associated epilepsy. |
| Q28066402 | Research for new drugs for elimination of onchocerciasis in Africa |
| Q42349843 | Response to the Letter to the Editor by Eberhard et al. |
| Q55209417 | Rethinking the serological threshold for onchocerciasis elimination. |
| Q33794662 | Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study |
| Q37414564 | Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment |
| Q90338599 | Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring |
| Q58600294 | Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys |
| Q89644271 | The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria |
| Q57182009 | The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis |
| Q37643713 | The genome of Onchocerca volvulus, agent of river blindness |
| Q53702860 | Transitioning from river blindness control to elimination: Steps toward stopping treatment |
Search more.